What is Amerise Biosciences share price return in the past 10 years?

Amerise Biosciences Ltd share price has declined -20.1% annually (CAGR) over the past ten years.

Amerise Biosciences Ltd - Stock Valuation and Financial Performance

Name: Amerise Biosciences
Brand: Amerise Biosciences

BSE: 531681 | NSE: | Finance - Investment | Small Cap

Place order

Amerise Biosciences Share Price

₹0.64 0.02 3.23%
as on 18-Apr'24 16:01

DeciZen - make an informed investing decision on Amerise Biosciences

Based on:

Data

M-Cap below 100cr DeciZen not available

Amerise Biosciences stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

4.2 Cr.

52-wk low:

0.5

52-wk high:

0.9

Is Amerise Biosciences Ltd an attractive stock to invest in?

1. Is Amerise Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Amerise Biosciences Ltd is a below average quality company.

2. Is Amerise Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Amerise Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Amerise Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Amerise Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Amerise Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Operating Income (₹ Cr.)	0	0	0	0	0	1.2	0	0	9	0	0
YoY Gr. Rt. %	-	NA	NA	NA	NA	NA	-100%	NA	NA	-100%	-
Adj EPS (₹ )	0	-0	0	-0.1	0	0	-0	-0.1	0.1	-0	-0
YoY Gr. Rt. %	-	NA	NA	NA	NA	NA	NA	NA	NA	-125%	-
BVPS (₹ )	1	1	1	0.9	0.8	0.8	0.8	0.8	0.9	0.8	0.8
YoY Gr. Rt. %	-	-1%	0%	-14.1%	-1.2%	0%	-2.4%	-6.1%	10.4%	-1.2%	-
To view Net Profit/Total Funds (%) Colour Rating Guide click here ⓘ
Net Profit/Total Funds (%)	-0.3	-0.7	-0.4	-15.4	-0.4	0.1	-2.6	-5.8	6.2	-1.4	0

CAGR ⓘ

CAGR Colour Code Guide ⓘ


	9 Years	5 Years	3 Years	1 Years
Net Interest Income	NA	NA	NA	-100%
Adj EPS	NA	NA	NA	-125%
BVPS	-1.9%	0%	0.8%	-1.2%
Share Price	-20.1%	-5.7%	-27.1%	-18%

Key Financial Ratios


RATIOS \ YEARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Margins
Net Profit Margin (%)	0	0	0	0	0	0.4	0	0	6.1	0	-INF
Performance Ratios	To view Performance Ratios Colour Rating Guide click here ⓘ
Return on Equity (%)	-0.4	-0.7	-0.4	-15.5	-0.4	0.1	-2.7	-6.4	10.2	-2.1	-3.5

Recent Performance Summary

No data to display

Return on Equity is Poor

Total Income has declined -25.00 CAGR in last 3 years

Net Profit has declined 0.00 CAGR in last 3 years

Total income growth is poor in last 4 quarters

Latest Financials - Amerise Biosciences Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	0.8	-
Reserves (₹ Cr.) ⓘ	-1	-
P/BV ⓘ	0.79	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.54 / 0.93
All Time Low / High (₹)	0.54 / 30.00
Market Cap (₹ Cr.)	4.2
Equity (₹ Cr.)	6.6
Face Value (₹)	1
Industry PE ⓘ	46.1

Management X-Ray of Amerise Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Amerise Biosciences

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Amerise Biosciences

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Total Income (Cr.)

ROE (%)

BVPS (Rs.)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Income	0	0	0	0	0	1.18	0	0	9.58	0.01
Interest Income	0	0	0	0	0	1.18	0	0	9.01	0
Other Income ⓘ	0	0	0	0	0	0	0	0	0.57	0.01
Expenditure ⓘ	0.03	0.05	0.03	0.94	0.02	1.18	0.15	0.34	9.03	0.13
Interest Expense ⓘ	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ	0.03	0.05	0.03	0.07	0.02	1.17	0.15	0.11	9.03	0.13
Provisions	0	0	0	0.87	0	0	0	0.23	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.03	-0.05	-0.03	-0.94	-0.02	0	-0.15	-0.34	0.55	-0.12
Taxes ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0.03	-0.05	-0.03	-0.94	-0.02	0	-0.15	-0.34	0.55	-0.12
Adjusted EPS (₹)	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	-0.1	0.1	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Equity Capital	6.61	6.56	6.53	5.59	5.57	5.58	5.43	5.09	5.64	5.52
Share Capital ⓘ	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61
Reserves ⓘ	0	-0.05	-0.07	-1.01	-1.03	-1.03	-1.18	-1.52	-0.97	-1.09
Minority Interest	0	0	0	0	0	0	0	0	0	0
Long Term Borrowings	0.59	0	0	0	0	0	0	0	0.08	0.09
Current Liabilities	0	0	0.01	0.05	0.02	0.02	0.60	0.54	6.27	0.04
Trade Payables	0	0	0	0	0	0	0.48	0.48	6.27	0
Short term borrowings	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	-0.48	-0.48	-6.27	0
Total Liabilities ⓘ	7.20	6.56	6.54	5.64	5.60	5.60	6.02	5.63	11.99	5.65
Assets
Non Current Asset	5.16	2.87	6.48	2.91	2.88	1.11	6	5.61	5.76	5.63
Loan Asset	0	0	0	0	0	0	0	0	0	0
Other Non Current Asset ⓘ	5.16	2.87	6.48	2.91	2.88	1.11	6	5.61	5.76	5.63
Current Asset	2.05	3.69	0.06	2.73	2.72	4.49	0.03	0.02	6.23	0.01
Current Investment	0	2.53	0	0	0	0	0	0	0	0
Other Current Asset	2.05	1.16	0.06	2.73	2.72	4.49	0.03	0.02	6.23	0.01
Total Assets ⓘ	7.20	6.56	6.54	5.64	5.60	5.60	6.02	5.63	11.99	5.65

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	2.74	0.27	1.08	-3.56	-0.04	-1.78	4.89	-0.39	0.06	-0.13
Cash Flow From Investing Activity ⓘ	-0.58	0.32	-1.07	3.55	0.03	1.77	-4.89	0.39	-0.15	0.13
Cash Flow From Financing Activity ⓘ	-2.15	-0.59	0	0	0	0	0	0	0.08	0.01
Net Cash Flow ⓘ	0.02	0	0	-0.01	-0.01	-0.01	0.01	-0.01	-0.01	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Operational & Financial Ratios
EPS (₹)	0	0	0	0	0	0	0	0	0	0
DPS (₹)	0	0	0	0	0	0	0	0	0	0
BVPS (₹)	1	1	1	1	1	1	1	1	1	1
Performance Ratios
ROA (%)	-0.3	-0.7	-0.4	-15.4	-0.4	0.1	-2.6	-5.8	6.2	-1.4
ROE (%)	-0.4	-0.7	-0.4	-15.5	-0.4	0.1	-2.7	-6.4	10.2	-2.1
ROCE (%)	-0.3	-0.7	-0.4	-15.5	-0.4	0.1	-2.7	-6.4	10.2	-2.1
Valuation Parameters
Price/Book(x)	0.0	0.0	0.0	1.1	0.0	0.0	1.0	2.1	1.6	0.8

Amerise Biosciences Ltd Stock News

Amerise Biosciences Ltd FAQs

What is the share price of Amerise Biosciences?

Company share prices are keep on changing according to the market conditions. The closing price of Amerise Biosciences on 18-Apr-2024 16:01 is ₹0.64.

What is the market cap of Amerise Biosciences?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Apr-2024 16:01 the market cap of Amerise Biosciences stood at ₹4.23.

What is the P/E ratio of Amerise Biosciences?

The latest P/E ratio of Amerise Biosciences as of 18-Apr-2024 16:01 is 0.00.

What is the P/B ratio of Amerise Biosciences?

The latest P/B ratio of Amerise Biosciences as of 18-Apr-2024 16:01 is 0.79.

What is the 52-week high and low of Amerise Biosciences?

The 52-week high of Amerise Biosciences is ₹0.93 and the 52-week low is ₹0.54.

What is the TTM revenue of Amerise Biosciences?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amerise Biosciences is ₹0.00 ( Cr.) .

About Amerise Biosciences Ltd

Amradeep Industries was incorporated in 1984, by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment. On October 29, 2002 the name of the company was changed from Amstar Laminates to Amardeep Industries.

The board of directors of the company on September 5, 2003, had proposed to sub divide the existing 66,06,900 equity shares of Rs 10 each in to share of Rs 1 each.

The registered office of the company is located at 24, Laxmi Chambers, Navjeevan Press Road, Opposite Old Gujarat High Court, Ahmedabad, Gujarat-380014.

Business area of the company

The company is engaged in commodity trading and in financial year (FY) 2007 it entered into the trading of castor seeds.